Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

Hansen, Morten L., Sørensen, Rikke, Clausen, Mette T., Fog-Petersen, Marie Louise, Raunsø, Jakob, Gadsbøll, Niels, Gislason, Gunnar H., Folke, Fredrik +6 more·2010·Archives of Internal Medicine

DOI 10.1001/archinternmed.2010.271

Cited by (853)

Items 201–300 of 853

Oral Anticoagulation in Elderly Adults with Atrial Fibrillation: Integrating New Options with Old Concepts
Ignatius Gerardo E. Zarraga, Jack Kron · 2012 · Journal of the American Geriatrics Society
Contemporary Patterns of Discharge Aspirin Dosing After Acute Myocardial Infarction in the United States
Hurst M. Hall, James A. de Lemos, Jonathan R. Enriquez, Darren K. McGuire, S. Andrew Peng, Karen P. Alexander, Matthew T. Roe, Nihar R. Desai, Stephen D. Wiviott, Sandeep R. Das · 2014 · Circulation Cardiovascular Quality and Outcomes
Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation
Eduardo Aguilar, Ana María García-Díaz, Juan Francisco Sánchez Muñoz-Torrero, Lorenzo Ramón Álvarez, Mar Piedecausa, Gemma Arnedo, Manuel Monréal · 2012 · Thrombosis Research
Warfarin use and incidence of stroke in Japanese hemodialysis patients with atrial fibrillation
Kenji Yodogawa, Akiko Mii, Megumi Fukui, Yu‐ki Iwasaki, Meiso Hayashi, Tomohiro Kaneko, Yasushi Miyauchi, Shuichi Tsuruoka, Wataru Shimizu · 2015 · Heart and Vessels
Bleeding in cardiac patients prescribed antithrombotic drugs: electronic health record phenotyping algorithms, incidence, trends and prognosis
Laura Pasea, Sheng‐Chia Chung, Mar Pujades‐Rodríguez, Anoop D Shah, Samantha Alvarez‐Madrazo, Victoria Allan, James Teo, Daniel M. Bean, Reecha Sofat, Richard Dobson et al. · 2019 · BMC Medicine
Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives
Alessandro Di Minno, Gaia Spadarella, Emanuela Spadarella, Elena Tremoli, Giovanni Di Minno · 2015 · Thrombosis Research
Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease
Klaus Bonaventura, Alexander Wolfgang Leber, Christian Sohns, Mattias Roser, Leif‐Hendrik Boldt, Franz Xaver Kleber, Wilhelm Haverkamp, Marc Dorenkamp · 2012 · Clinical Research in Cardiology
Triple antithrombotic therapy in cardiac patients: more questions than answers.
M. Moser, C. Olivier, C. Bode · 2014 · European Heart Journal
Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease
Morten Lamberts, Gregory Y.H. Lip, Martin Huth Ruwald, Morten Lock Hansen, Cengiz Özcan, Søren Lund Kristensen, Lars Køber, Christian Tobias Torp-Pedersen, Gunnar Gislason · 2014 · Journal of the American College of Cardiology
Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention.
Nayan Agarwal, Ankur Jain, Ahmed N. Mahmoud, R. Bishnoi, H. Golwala, Ashkan Karimi, M. Mojadidi, Jalaj Garg, Tanush Gupta, N. Patel et al. · 2017 · American Journal of Medicine
Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report
Vinod Bansal, Charles A. Herzog, Mark J. Sarnak, Michael Jin Choi, Ravindra L. Mehta, Bernard G. Jaar, Michael V. Rocco, Holly Kramer · 2017 · American Journal of Kidney Diseases
Management of Acute Coronary Syndrome in Cancer Patients: It’s High Time We Dealt with It
Fabiana Lucà, Iris Parrini, Maurizio Giuseppe Abrignani, Carmelo Massimiliano Rao, Laura Piccioni, Stefania Angela Di Fusco, Roberto Ceravolo, Irma Bisceglia, Carmine Riccio, Sandro Gelsomino et al. · 2022 · Journal of Clinical Medicine
Peripheral artery disease and atrial fibrillation: a potentially dangerous combination
Francesco Violi, Gregory Y.H. Lip, Stefania Basili · 2011 · Internal and Emergency Medicine
Atrial Fibrillation and Vascular Disease—A Bad Combination
Jonas Bjerring Olesen, Gunnar Gislason, Christian Tobias Torp-Pedersen, Gregory Y.H. Lip · 2012 · Clinical Cardiology
Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review
Deirdre A. Lane, Smriti Raichand, David Moore, Martin J Connock, Anne Fry-Smith, DA Fitzmaurice · 2013 · Health Technology Assessment
Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study
Pei‐Chun Chen, Gregory Y.H. Lip, Grace Yeh, Hung‐Ju Lin, Kuo‐Liong Chien · 2015 · PLoS ONE
The risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease
Ashwin S. Nathan, Sounok Sen, Robert W. Yeh · 2017 · Expert Opinion on Drug Safety
Predictors and long-term prognosis of left ventricular aneurysm in patients with acute anterior myocardial infarction treated with primary percutaneous coronary intervention in the contemporary era
Jieyun You, Liming Gao, Yunli Shen, Wei Guo, Xingxu Wang, Qing Wan, Xiaoyan Wang, Jian Wu, Qi Zhang · 2021 · Journal of Thoracic Disease
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding
Davide Cao, Nicolas Amabile, Mauro Chiarito, Victoria T. Lee, Dominick Joseph Angiolillo, Davide Capodanno, Deepak L. Bhatt, Michael J. Mack, Robert F. Storey, Michael Schmoeckel et al. · 2023 · European Heart Journal
Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001
Autoren, Collaborators: · 2023 · Zeitschrift für Gastroenterologie
Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease
Steen Husted, Lars C. Wallentin, Felicita Andreotti, Harald Arnesen, F Bachmann, Colin Baigent, Jean‐Philippe Collet, Sigrun Halvorsen, Kurt Huber, Jørgen Jespersen et al. · 2016 · Thrombosis and Haemostasis
Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding
Pasquale Pignatelli, Daniele Pastori, Simona Bartimoccia, Danilo Menichelli, Tommasa Vicario, Cristina Nocella, Roberto Carnevale, Francesco Violi · 2016 · Pharmacological Research
Atrial fibrillation and stroke: a practical guide
Jonathan G. Best, Robert Bell, Mohammad Mahfuzul Haque, Arvind Chandratheva, David John Werring · 2019 · Practical Neurology
Left Atrial Appendage Occlusion in Non-Valvular Atrial Fibrillation in a Korean Multi-Center Registry
Jung‐Sun Kim, Hancheol Lee, Yongsung Suh, Hui‐Nam Pak, Geu‐Ru Hong, Chi Young Shim, Cheol Woong Yu, Hyun‐Jong Lee, Woong Chol Kang, Eun‐Seok Shin et al. · 2016 · Circulation Journal
Position Statement on Antiplatelet Therapy for East Asians With Coronary Artery Disease
Yanjun Gong, Young‐Hoon Jeong, Tzung‐Dau Wang, Jack Wei Chieh Tan, Juying Qian, Hongbing Yan, Mark Y. Chan, Yundai Chen, Shuning Zhang, Zuyi Yuan et al. · 2025 · JACC Asia
A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks
Beata V. Bajorek · 2011 · Therapeutic Advances in Drug Safety
Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry — POL-TAVI
Katarzyna Czerwińska, Marian Zembala, Maciej Dąbrowski, Adam Witkowski, Andrzej J. Ochala, Janusz Kochman, Dariusz Dudek, Piotr Kübler, Dariusz Jagielak, Janina Stępińska · 2016 · International Journal of Cardiology
The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
Junbo Zou, Xiaofei Zhang, Jing Wang, Fang Wang, Jiangxue Cheng, Fang-Yan Yang, Xiao Song, Yu Wang, Yulin Liang, Yajun Shi · 2018 · Frontiers in Pharmacology
Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention
Konstantinos C. Koskinas, Lorenz Räber, Thomas Zanchin, Thomas Pilgrim, Stefan Stortecky, Lukas Hunziker, Stefan Blöchlinger, Michael Billinger, Fabienne Gartwyl, Christina Moro et al. · 2016 · JACC: Cardiovascular Interventions
Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals
Vincent Johan Nijenhuis, Pieter R. Stella, Jan Baan, B.R.G. Brueren, Peter P.T. de Jaegere, Peter den Heijer, Sjoerd H. Hofma, Peter C. Kievit, Ton Slagboom, Ad F.M. van den Heuvel et al. · 2013 · Netherlands Heart Journal
Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
A. Sambola, M. Mutuberría, B. García Del Blanco, Albert Alonso, J. Barrabés, H. Bueno, F. Alfonso, Á. Cequier, J. Zueco, O. Rodriguez-Leor et al. · 2016 · PLoS ONE
Poor adherence to guideline recommendations among patients with atrial fibrillation and acute myocardial infarction
Jarle Jortveit, Are Hugo Pripp, Jørund Langørgen, Sigrun Halvorsen · 2019 · European Journal of Preventive Cardiology
Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease
Miklós Rohla, Christoph Kleine Vennekate, Ioannis Tentzeris, Matthias Karl Freynhofer, Serdar Farhan, Florian Egger, Thomas Werner Weiss, Johann Wojta, Christopher Bull Granger, Kurt Huber · 2015 · International Journal of Cardiology
Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research
Alessandro Di Minno, Gaia Spadarella, Domenico Prisco, Antonella Scalera, Elena Ricciardi, Giovanni Di Minno · 2015 · Blood Reviews
From Patients to Platelets and Back Again: Pharmacological Approaches to Glycoprotein VI, a Thrilling Antithrombotic Target with Minor Bleeding Risks
Augusto Martins Lima, Ana C. Martins Cavaco, Rodrigo A. Fraga‐Silva, Johannes Andreas Eble, Nikolaos Stergiopulos · 2019 · Thrombosis and Haemostasis
Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation
Emer R. McGrath, Moira K. Kapral, Jiming Fang, John W. Eikelboom, Aengus ó Conghaile, Michelle D. Canavan, Martin James O'Donnell · 2014 · Stroke
Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications
Angel Yi Nam Fu, Kuljit Singh, Joseph G. Abunassar, Nikita Malhotra, Michel R. Le May, Marino X. Labinaz, Christopher A. Glover, Jean-François Marquis, Michael P.V. Froeschl, ALEXANDER J. DICK et al. · 2016 · Clinical Cardiology
Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation
Emil Loldrup Fosbøl, Naja Emborg Vinding, Morten Lamberts, Laila Stærk, Anna Gundlund, Kasper Gadsbøll, Lars Køber, Gunnar Gislason, Jonas Bjerring Olesen · 2017 · EP Europace
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation
Kurt Huber, Stuart J. Connolly, A Kher, François Christory, Gheorghe‐Andrei Dan, Róbert Hatala, Róbert Gábor Kiss, Bernhard Meier, Béla Péter Merkely, Burkert Mathias Pieske et al. · 2013 · International Journal of Clinical Practice
Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective
Raúl Altman, Hector O Vidal · 2011 · Thrombosis Journal
Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention
Matthew William Sherwood, Derek D. Cyr, W. Schuyler Jones, Richard Clinton Becker, Scott D. Berkowitz, Jeffrey B. Washam, GÜNTER E. BREITHARDT, Keith A.A. Fox, Jonathan L. Halperin, Graeme J. Hankey et al. · 2016 · JACC: Cardiovascular Interventions
Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran
Jennifer M. Kolb, Kathryn Friedman Flack, Prapti Chatterjee-Murphy, Jay Desai, Lars C. Wallentin, Michael D. Ezekowitz, Stuart J. Connolly, Paul A. Reilly, Martina Brueckmann, John P. Ilgenfritz et al. · 2018 · Digestive Diseases and Sciences
A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC
Patrick Blin, Caroline Dureau‐Pournin, R. Lassalle, Abdelilah Abouelfath, Cécile Droz‐Perroteau, Nicholas D Moore · 2015 · British Journal of Clinical Pharmacology
Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease
Steven J. Ross, Islam Y. Elgendy, Anthony A. Bavry · 2017 · Current Cardiology Reports
The prognostic effect of left ventricular thrombus formation after acute myocardial infarction in the contemporary era of primary percutaneous coronary intervention: A meta-analysis
Pengfei Chen, Liang Tang, Jun‐lin Yi, Junyu Pei, Xinqun Hu · 2019 · European Journal of Internal Medicine
Assessment of oral antithrombotic therapy by platelet function testing
Udaya S. Tantry, Paul Alfred Gurbel · 2011 · Nature Reviews Cardiology
Efficacy and safety of antithrombotic regimens after coronary intervention in patients on oral anticoagulation: Traditional and Bayesian meta-analysis of clinical trials
Jian Liu, Meida Fan, Jingjing Zhao, Bing-Cheng Zhao, Chongyu Zhang, Chen Liu, Yugang Dong · 2015 · International Journal of Cardiology
Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification
Antonia Sambola, Maria Mutuberría, Bruno García del Blanco, Albert Alonso, José A. Barrabés, Fernándo Alfonso, Héctor Bueno, Angel R. Cequier, Javier Zueco, Oriol Rodríguez-leor C et al. · 2015 · Circulation Journal
The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trials
Thomas A. Zelniker, Christian Thomas Ruff, Elliott Marshall Antman, Robert Patrick Giugliano · 2018 · European Heart Journal Acute Cardiovascular Care
Efficacy of stenting in patients with cerebral venous sinus thrombosis-related cerebral venous sinus stenosis
Ke Li, Ming Ren, Ran Meng, Yuchuan Ding, Gary Benjamin Rajah, Feng Wang, Xunming Ji · 2018 · Journal of NeuroInterventional Surgery
Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?
James Demetrios Douketis · 2011 · Thrombosis Research
Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?
Yann Ancédy, Coralie Lecoq, Christophe Saint Etienne, Fabrice Ivanés, Denis Angoulvant, Dominique Babuty, Gregory Y.H. Lip, Laurent Fauchier · 2015 · International Journal of Cardiology
Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation
Christina Ji‐Young Lee, Jannik Langtved Pallisgaard, Jonas Bjerring Olesen, Nicholas Carlson, Morten Lamberts, Gunnar Gislason, Christian Tobias Torp-Pedersen, Axel Brandes, Steen Husted, Søren Paaske Johnsen et al. · 2017 · Journal of the American College of Cardiology
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes
Renato D. Lópes, Jennifer A. White, Dan Atar, Mátyás Keltai, Neal S. Kleiman, Harvey Douglas White, Petr Widimský, Uwe Zeymer, Robert Patrick Giugliano, Pierluigi Tricoci et al. · 2013 · International Journal of Cardiology
Can Anticoagulated Patients be Discharged Home Safely from the Emergency Department after Minor Head Injury?
Brian G. Cohn, Samuel M. Keim, Arthur B. Sanders · 2013 · Journal of Emergency Medicine
Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension
Laurence Gabriel, Xavier Delavenne, Pierrick Bedouch, C. Khouatra, Hélène Bouvaist, Jean-François Cordier, Jean‐François Mornex, Christophe M. Pison, Vincent Cottin, Laurent Bertoletti · 2016 · Respiration
Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y12inhibitors
Michael A. Mazzeffi, Khang Lee, Bradley S. Taylor, Kenichi A. Tanaka · 2017 · Korean Journal of Anesthesiology
PPIs and Beyond: A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19
Parita Patel, Neil Sengupta · 2020 · Digestive Diseases and Sciences
Modern Management of Acute Myocardial Infarction
Terrence D. Welch, Eric H. Yang, Guy S. Reeder, Bernard John Gersh · 2012 · Current Problems in Cardiology
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Roffi, Marco, Patrono, Carlo, Collet, Jean-Philippe, Mueller, Christian, Valgimigli, Marco, Andreotti, Felicita, Bax, Jeroen J., Borger, Michael A., Brotons, Carlos, Chew, Derek P. et al. · 2016 · European Heart Journal
New targets for antithrombotic medications: seeking to decouple thrombosis from hemostasis
Geoffrey D. Barnes · 2024 · Journal of Thrombosis and Haemostasis
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients
Connie Ng Hess, Samuel Broderick, Jonathan Paul Piccini, Karen P. Alexander, Laura Kristin Newby, Linda K. Shaw, Kenneth W. Mahaffey, John Hunter Alexander, Eric David Peterson, Christopher Bull Granger et al. · 2012 · American Heart Journal
A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease
Robert C. Welsh, Matthew T. Roe, Philippe Gabríel Steg, Stefan Karl James, Thomas Joseph Povsic, Christoph Bode, Charles Michael Gibson, E. Magnus Ohman · 2016 · American Heart Journal
Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations
Zachary A. Stacy, Sara K. Richter · 2018 · Therapeutic Advances in Cardiovascular Disease
The Association of Drugs With Severity and Specific Causes of Acute Lower Gastrointestinal Bleeding
Jóhann P. Hreinsson, Solrun Palsdóttir, Einar Stefan Bjornsson · 2015 · Journal of Clinical Gastroenterology
Relationship of left ventricular thrombus formation and adverse outcomes in acute anterior myocardial infarction in patients treated with primary percutaneous coronary intervention
Qian Zhang, Chunmei Wang, Shutian Shi, Hong Chen, Yujie Zhou · 2018 · Clinical Cardiology
Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation ― The Fushimi AF Registry ―
Nobutoyo Masunaga, Mitsuru Abe, Hisashi Ogawa, Yuya Aono, Syuhei Ikeda, Kosuke Doi, Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Masahiro Esato et al. · 2018 · Circulation Journal
Nucleic Acid Therapies for Ischemic Stroke
Nils Henninger, Yunis M. Mayasi · 2019 · Neurotherapeutics
Clopidogrel Drug Interactions and Serious Bleeding: Generating Real‐World Evidence via Automated High‐Throughput Pharmacoepidemiologic Screening
Charles E. Leonard, Meijia Zhou, Colleen M Brensinger, Warren B. Bilker, Samantha E. Soprano, Thanh Phuong Pham Nguyen, Young Hee Nam, Jordana B. Cohen, Sean Hennessy · 2019 · Clinical Pharmacology & Therapeutics
Antithrombotic therapy – predictor of early and long-term bleeding complications after transcatheter aortic valve implantation
Katarzyna Czerwińska, Adam Witkowski, Maciej Dąbrowski, Marek Banaszewski, Ewa Księżycka, Zbigniew Chmielak, Krzysztof Kuśmierski, Tomasz Hryniewiecki, Marcin Demkow, Ewa Orłowska‐Baranowska et al. · 2013 · Archives of Medical Science
Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay
Christoph Liebetrau, Michael W. Weber, Stergios Tzikas, Lars Palapies, Helge Möllmann, Gerhard Pioro, Tanja Zeller, Andrés Beiras-Fernández, Christoph Bickel, Andreas Michael Zeiher et al. · 2015 · BMC Medicine
Cost‐Effectiveness of Paclitaxel‐Coated Balloon Angioplasty in Patients With Drug‐Eluting Stent Restenosis
Marc Dorenkamp, Julia Boldt, Alexander Wolfgang Leber, Christian Sohns, Mattias Roser, Leif‐Hendrik Boldt, Wilhelm Haverkamp, Klaus Bonaventura · 2013 · Clinical Cardiology
Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry
Marco Proietti, Juhani K.E. Airaksinen, Andrea Rubboli, Axel Schlitt, Tuomas Kiviniemi, Pasi Paavo Karjalainen, Gregory Y.H. Lip · 2017 · American Heart Journal
Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities
Masahisa Arahata, Hidesaku Asakura · 2018 · Clinical Interventions in Aging
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta‐analysis
Emanuele Valeriani, Ettore Porreca, Jeffrey Ian Weitz, Sam Schulman, Matteo Candeloro, Marcello Di Nisio · 2020 · Journal of Thrombosis and Haemostasis
Anti-thrombotic strategies in elderly patients receiving platelet inhibitors
Andreas Schäfer, Ulrike Flierl, Johann K Bauersachs · 2019 · European Heart Journal - Cardiovascular Pharmacotherapy
Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study.
K. A. Fiedler, R. Byrne, S. Schulz, D. Sibbing, J. Mehilli, T. Ibrahim, M. Maeng, K. Laugwitz, A. Kastrati, N. Sarafoff · 2014 · American Heart Journal
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis
Monica Verdoia, Lucia Barbieri, Matteo Nardin, Harry Suryapranata, Giuseppe De Luca · 2017 · Revista Española de Cardiología (English Edition)
Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022
Jacek Kubica, Piotr Adamski, Jerzy R. Ładny, Jarosław Kaźmierczak, Tomasz Fabiszak, Krzysztof J. Filipiak, Robert Gajda, Mariusz Gąsior, Zbigniew Gąsior, Robert Gil et al. · 2022 · Cardiology Journal
Optimal Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Focused Review on High Bleeding Risk
Yunosuke Matsuura, Kohei Moribayashi, Koichi Kaikita · 2022 · Journal of Atherosclerosis and Thrombosis
Antiplatelet Strategies Following PCI: A Review of Trials Informing Current and Future Therapies
Alexander W. Thomas, Mauro Gitto, Samit Shah, Yuichi Saito, Daniela Tı̂rziu, Alaide Chieffo, Giulio Giuseppe Stefanini, Alexandra J. Lansky · 2023 · Journal of the Society for Cardiovascular Angiography & Interventions
Clinical management of rivaroxaban-treated patients
Gualtiero Palareti, Walter Ageno, Annamaria Ferrari, Alessandro Filippi, Davide Imberti, Vittorio Pengo, Andrea Rubboli, Danilo Toni · 2013 · Expert Opinion on Pharmacotherapy
Antiplatelet and Anticoagulant Therapy in Patients With Gastrointestinal Bleeding
Majid Abdularahman Almadi, Alan N. Barkun, James M. Brophy · 2011 · JAMA
Update on the management of atrial fibrillation
John V. Amerena, Tomos E. Walters, Sam Mirzaee, Jonathan M. Kalman · 2013 · The Medical Journal of Australia
Natural history of bleeding and characteristics of early bleeders among warfarin initiators – a cohort study in Finland
Maarit Jaana Korhonen, Maria Rikala, Helena Kastarinen, Pekka Tiittanen, Risto Huupponen · 2016 · Clinical Epidemiology
Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
João Morais, Raffaele De Caterina · 2016 · Cardiovascular Drugs and Therapy
Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation
Daniele Pastori, Pasquale Pignatelli, Alessio Farcomeni, Cristina Nocella, Simona Bartimoccia, Roberto Carnevale, Francesco Violi · 2016 · Oncotarget
P2Y12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis
Florentino A. Lupercio, Shaun Giancaterino, Pedro Arturo Villablanca, Frederick T. Han, Kurt S. Hoffmayer, Gordon Ho, Farshad Raissi, David E. Krummen, Ulrika Maria Birgersdotter-Green, Gregory K. Feld et al. · 2020 · Heart
EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION
Golitsyn Sp, Е. П. Панченко, Кропачева Екатерина Станиславовна, Lada Iu. Laiovich, E. B. Maykov, Nikolay Yu. Mironov, Olga O. Shakhmatova · 2019 · Eurasian heart journal
Antiplatelet agents in cardiovascular disease
Renato D. Lópes · 2011 · Journal of Thrombosis and Thrombolysis
Management of anticoagulant-related intracranial hemorrhage: an evidence-based review
Bappaditya S Ray, Salah G. Keyrouz · 2014 · Critical Care
Bleeding risks associated with vitamin K antagonists
Lori‐Ann Linkins · 2013 · Blood Reviews
Net clinical benefit of edoxaban versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
Andrew D. Blann, Amitava Banerjee, Deirdre A. Lane, Christian Tobias Torp-Pedersen, Gregory Y.H. Lip · 2015 · International Journal of Cardiology
Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs
Raúl Altman, Claudio Daniel González · 2014 · Thrombosis Journal
Dual Antiplatelet Therapy Is Associated With Coagulopathy Detectable by Thrombelastography in Acute Stroke
Mark M. McDonald, Tareq S Almaghrabi, Daniel M. Saenz, Chunyan C. Cai, Mohammad H. Rahbar, Huimahn Alex Choi, Kiwon Lee, James C. Grotta, Tiffany R. Chang · 2017 · Journal of Intensive Care Medicine
Toxicity of thienopyridines on human neutrophil granulocytes and lymphocytes
Swarna Maseneni, Massimiliano Donzelli, Karin Brecht, Stephan Krähenbühl · 2013 · Toxicology
Admission International Normalized Ratio Levels, Early Treatment Strategies, and Major Bleeding Risk Among Non–ST-Segment–Elevation Myocardial Infarction Patients on Home Warfarin Therapy
Sumeet Subherwal, Eric David Peterson, Anita Y. Chen, Matthew T. Roe, Jeffrey B. Washam, Brian F. Gage, Richard G. Bach, Deepak L. Bhatt, Stephen D. Wiviott, Renato D. Lópes et al. · 2012 · Circulation
Aspirin and Clopidogrel for Prevention of Ischemic Stroke
Ruth M. Thomson, David C. Anderson · 2013 · Current Neurology and Neuroscience Reports
Antiplatelet therapy in prevention of cardio- and venous thromboembolic events
Steven R. Steinhubl, John W. Eikelboom, Elaine M. Hylek, Harold L. Dauerman, Susan S. Smyth, Richard Clinton Becker · 2013 · Journal of Thrombosis and Thrombolysis
Hemarthrosis in a Patient on Warfarin Receiving Ceftaroline: A Case Report and Brief Review of Cephalosporin Interactions with Warfarin
Nicole M Bohm, Brittany Crosby · 2012 · Annals of Pharmacotherapy